Literature DB >> 8257453

Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

A Bowie1, D Owens, P Collins, A Johnson, G H Tomkin.   

Abstract

Oxidised low density lipoprotein (LDL) is considered to be atherogenic. This study examined the relationship between glycosylation and oxidation of LDL from 10 normocholesterolaemic Type 2 diabetic patients, 10 hypercholesterolaemic Type 2 diabetic patients, and 10 normocholesterolaemic non-diabetic subjects. LDL was isolated by sequential ultracentrifugation and susceptibility to oxidation assessed by measuring thiobarbituric reactive substances (TBARS) during a 4-h oxidation period. LDL glycosylation was measured by aminophenylborate gel chromatography. Results demonstrated an increased susceptibility to oxidation in LDL from both diabetic groups, the mean 3-h TBARS values being 35.2 +/- 2.1 and 36.4 +/- 2.6 nmol MDA/mg LDL protein for normocholesterolaemic and hypercholesterolaemic diabetic patients compared with 24.5 +/- 2.5 nmol MDA/mg LDL protein for control subjects. LDL glycosylation of 2.20% +/- 0.11% and 2.89% +/- 0.46% for normocholesterolaemic and hypercholesterolaemic diabetic LDL was significantly higher than that for the non-diabetic control subjects of 1.60% +/- 0.12% (P < 0.02). There was a significant positive correlation (P < 0.005) between LDL glycosylation and LDL oxidation. The esterified/free cholesterol ratio which correlated positively with oxidation (P < 0.01) was significantly higher in LDL from both diabetic groups compared with LDL from control subjects (P < 0.01). Thus the increased incidence of atherosclerosis in diabetes may be related to glycosylation of LDL through its increased susceptibility to oxidation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257453     DOI: 10.1016/0021-9150(93)90084-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  23 in total

1.  Robert Graves Memorial Lecture. Diabetes and atherosclerosis--a gut review.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

Review 2.  Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

Review 3.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.

Authors:  T Kobayashi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 5.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 6.  Clinical significance of the physicochemical properties of LDL in type 2 diabetes.

Authors:  P G Scheffer; T Teerlink; R J Heine
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

7.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

8.  Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.

Authors:  Wenyu Wang; Sohail Khan; Piers Blackett; Petar Alaupovic; Elisa Lee
Journal:  J Clin Lipidol       Date:  2012-07-02       Impact factor: 4.766

9.  Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Authors:  P Nivoit; N Wiernsperger; P Moulin; M Lagarde; C Renaudin
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

Review 10.  Oxidative stress and diabetic vascular complications.

Authors:  Seok Man Son; Matthew K Whalin; David G Harrison; W Robert Taylor; Kathy K Griendling
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.